Bausch + Lomb Corp (BLCO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
OPHTHALMIC GOODS
CEO:
Joseph C. Papa
Employees:
12,500
1800 - 510 WEST GEORGIA STREET, VANCOUVER, CANADA BC V6B 0M3
908-541-5456

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.Our business was founded in 1853 and incorporated in the State of New York in 1908 (“Old Bausch + Lomb”). Our executive offices are located at 520 Applewood Crescent, Vaughan, Ontario, Canada.

Data derived from most recent annual or quarterly report
Market Cap 5.945 Billion Shares Outstanding350.715 Million Avg 30-day Volume 434.793 Thousand
P/E Ratio905.267 Dividend Yield0.0 EPS-0.09
Price to Revenue1.4415 Debt to Equity0.3431 EBITDA600 Million
Price to Book Value0.7723 Operating Margin5.4936 Enterprise Value7.556 Billion
Current Ratio1.649 EPS Growth-0.962 Quick Ratio0.832
1 Yr BETA 1.0021 52-week High/Low 21.95 / 12.79 Profit Margin0.3981
Operating Cash Flow Growth-60.4811 Free Cash Flow to Firm (FCFF) TTM 110.534 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score1.2986
View SEC Filings from BLCO instead.

View recent insider trading info

Bausch + Lomb Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BLCO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLCO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-27 by MUNSCH FREDERICK
  • 4: filed on 2023-07-27 by HASHAD YEHIA
  • 4: filed on 2023-07-27 by BONNEFOY LUC
  • 4: filed on 2023-07-05 by ROBERTSON RUSSEL C
  • 4: filed on 2023-07-05 by PAULSON JOHN
  • 4: filed on 2023-07-05 by BERNIER NATHALIE D.
  • 4: filed on 2023-06-16 by BONNEFOY LUC
  • 3: filed on 2023-06-12 by BONNEFOY LUC
  • 4: filed on 2023-05-05 by BAILEY A ROBERT D
  • 4: filed on 2023-05-05 by VON ESCHENBACH ANDREW C.

    • Events (8k)

  • 8-K: filed on 2023-09-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-08-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-08-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-30:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ELDESSOUKY SAM EVP AND CFO

    • Officer
    		 198,299 2023-07-25 2

    MUNSCH FREDERICK SVP, CONTROLLER AND CAO

    • Officer
    		 39,938 2023-07-25 2

    HASHAD YEHIA EVP OF R&D AND CMO

    • Officer
    		 83,441 2023-07-25 2

    BONNEFOY LUC PRESIDENT, SURGICAL

    • Officer
    		 42,489 2023-07-25 3

    DE SCHUTTER RICHARD U

    • Director
    		 28,239 2023-06-30 3

    PAULSON JOHN

    • Director
    		 27,702 2023-06-30 3

    ROBERTSON RUSSEL C

    • Director
    		 21,412 2023-06-30 4

    BERNIER NATHALIE D.

    • Director
    		 31,690 2023-06-30 5

    ICAHN BRETT

    • Director
    		 26,113 2023-05-04 1

    VON ESCHENBACH ANDREW C.

    • Director
    		 25,357 2023-05-04 1

    BAILEY A ROBERT D EVP & CHIEF LEGAL OFFICER

    • Officer
    		 0 2023-05-04 3

    ROSS THOMAS W. SR.

    • Director
    		 25,357 2023-05-04 1

    KAVANAGH SARAH B

    • Director
    		 18,665 2023-05-04 2

    HU GAOXIANG

    • Director
    		 26,113 2023-05-04 1

    STEWART ANDREW J. SEE REMARKS

    • Officer
    		 0 2023-04-24 2

    SAUNDERS BRENT L CEO AND CHAIR

    • Officer
    • Director
    		 375,000 2023-03-06 2

    ACKERMANN CHRISTINA PLEASE SEE REMARKS

    • Officer
    		 146,677 2023-03-01 1

    GORDON JOSEPH F PLEASE SEE REMARKS

    • Officer
    		 125,702 2023-03-01 1

    BAUSCH HEALTH COMPANIES INC.

    • 10% Owner
    		 310,449,643 2022-06-01 0

    PAPA JOSEPH C SEE REMARKS

    • Officer
    • Director
    		 0 2022-05-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BAUSCH + LOMB CORP BLCO 2023-10-02 22:15:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 21:45:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 21:15:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 20:45:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 20:15:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 19:45:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 19:15:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 18:45:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 18:15:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 17:45:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 17:15:03 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 16:45:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 16:15:04 UTC 1.1115 4.2085 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 15:45:04 UTC 1.1341 4.1859 900000
    BAUSCH + LOMB CORP BLCO 2023-10-02 15:15:04 UTC 1.1341 4.1859 300000
    BAUSCH + LOMB CORP BLCO 2023-10-02 14:45:03 UTC 1.1341 4.1859 300000
    BAUSCH + LOMB CORP BLCO 2023-10-02 14:15:03 UTC 1.1341 4.1859 300000
    BAUSCH + LOMB CORP BLCO 2023-10-02 13:45:04 UTC 1.5419 3.7781 300000
    BAUSCH + LOMB CORP BLCO 2023-10-02 13:15:05 UTC 1.5419 3.7781 300000
    BAUSCH + LOMB CORP BLCO 2023-10-02 12:45:05 UTC 1.5419 3.7781 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Franklin Mutual Series Funds- Franklin Mutual Quest Fund BLCO -172546.0 shares, $-3462998.22 2023-06-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BLCO -4900.0 shares, $-98343.0 2023-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments